Thus, Meerschaut et al. developed a novel clinical scoring system for patients with suspected CCA but without a pathogenic FBN2 variant, intellectual disability, ectopia lentis, and/or progressive aortic root dilatation. This evidence concerns the gene FBN2 and congenital contractural arachnodactyly.